Linking landscape attributes to salmon and decision-making in the southern Kenai Lowlands, Alaska, USA
In: Ecology and society: E&S ; a journal of integrative science for resilience and sustainability, Band 25, Heft 4
ISSN: 1708-3087
146 Ergebnisse
Sortierung:
In: Ecology and society: E&S ; a journal of integrative science for resilience and sustainability, Band 25, Heft 4
ISSN: 1708-3087
In: Middle East report: MER ; Middle East research and information project, MERIP, Band 19, Heft 158, S. 6-11
ISSN: 0888-0328, 0899-2851
Before NASA's Dawn mission, the dwarf planet Ceres was widely believed to contain a substantial ice-rich layer below its rocky surface. The existence of such a layer has significant implications for Ceres's formation, evolution, and astrobiological potential. Ceres is warmer than icy worlds in the outer Solar System and, if its shallow subsurface is ice-rich, large impact craters are expected to be erased by viscous flow on short geologic timescales. Here we use digital terrain models derived from Dawn Framing Camera images to show that most of Ceres's largest craters are several kilometres deep, and are therefore inconsistent with the existence of an ice-rich subsurface. We further show from numerical simulations that the absence of viscous relaxation over billion-year timescales implies a subsurface viscosity that is at least one thousand times greater than that of pure water ice. We conclude that Ceres's shallow subsurface is no more than 30% to 40% ice by volume, with a mixture of rock, salts and/or clathrates accounting for the other 60% to 70%. However, several anomalously shallow craters are consistent with limited viscous relaxation and may indicate spatial variations in subsurface ice content. ; Published (Publication status) ; Public domain authored by a U.S. government employee
BASE
In: Marine policy, Band 60, S. 182-185
ISSN: 0308-597X
In: Marine policy: the international journal of ocean affairs, Band 60, S. 182-185
ISSN: 0308-597X
In: Marine policy, Band 79, S. 78-83
ISSN: 0308-597X
Voters may be unable to hold politicians to account if they lack basic information about their representatives' performance. Civil society groups and international donors therefore advocate using voter information campaigns to improve democratic accountability. Yet, are these campaigns effective? Limited replication, measurement heterogeneity, and publication biases may undermine the reliability of published research. We implemented a new approach to cumulative learning, coordinating the design of seven randomized controlled trials to be fielded in six countries by independent research teams. Uncommon for multisite trials in the social sciences, we jointly preregistered a meta-analysis of results in advance of seeing the data. We find no evidence overall that typical, nonpartisan voter information campaigns shape voter behavior, although exploratory and subgroup analyses suggest conditions under which informational campaigns could be more effective. Such null estimated effects are too seldom published, yet they can be critical for scientific progress and cumulative, policy-relevant learning.
BASE
In: Science Advances
A preregistered meta-analysis of six field experiments finds no evidence overall that information campaigns shape voter behavior.
Frontmatter -- Contents -- Acknowledgments -- Introduction: Misinformation among Mass Audiences as a Focus for Inquiry -- PART I Dimensions of Audience Awareness of Misinformation -- ONE Believing Things That Are Not True: A Cognitive Science Perspective on Misinformation -- TWO Awareness of Misinformation in Health-Related Advertising: A Narrative Review of the Literature -- THREE The Importance of Measuring Knowledge in the Age of Misinformation and Challenges in the Tobacco Domain -- FOUR Measuring Perceptions of Shares of Groups -- FIVE Dimensions of Visual Misinformation in the Emerging Media Landscape -- PART II Theoretical Effects and Consequences of Misinformation -- SIX The Effects of False Information in News Stories -- SEVEN Can Satire and Irony Constitute Misinformation? -- EIGHT Media and Political Misperceptions -- NINE Misinformation and Science: Emergence, Diffusion, and Persistence -- TEN Doing the Wrong Things for the Right Reasons: How Environmental Misinformation Affects Environmental Behavior -- PART III Solutions and Remedies for Misinformation -- ELEVEN Misinformation and Its Correction: Cognitive Mechanisms and Recommendations for Mass Communication -- TWELVE How to Counteract Consumer Product Misinformation -- THIRTEEN A History of Fact Checking in U.S. Politics and Election Contexts -- FOURTEEN Comparing Approaches to Journalistic Fact Checking -- FIFTEEN The Role of Middle-Level Gatekeepers in the Propagation and Longevity of Misinformation -- SIXTEEN Encouraging Information Search to Counteract Misinformation: Providing "Balanced" Information about Vaccines -- Conclusion: An Agenda for Misinformation Research -- Contributors -- Index
© 2019 World Health Organization Background: Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality trends. Methods: In this longitudinal, population-based study, we collected patient-level data on 3·9 million patients with cancer from population-based cancer registries in 21 jurisdictions in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the UK) for seven sites of cancer (oesophagus, stomach, colon, rectum, pancreas, lung, and ovary) diagnosed between 1995 and 2014, and followed up until Dec 31, 2015. We calculated age-standardised net survival at 1 year and 5 years after diagnosis by site, age group, and period of diagnosis. We mapped changes in incidence and mortality to changes in survival to assess progress in cancer control. Findings: In 19 eligible jurisdictions, 3 764 543 cases of cancer were eligible for inclusion in the study. In the 19 included jurisdictions, over 1995–2014, 1-year and 5-year net survival increased in each country across almost all cancer types, with, for example, 5-year rectal cancer survival increasing more than 13 percentage points in Denmark, Ireland, and the UK. For 2010–14, survival was generally higher in Australia, Canada, and Norway than in New Zealand, Denmark, Ireland, and the UK. Over the study period, larger survival improvements were observed for patients younger than 75 years at diagnosis than those aged 75 years and older, and notably for cancers with a poor prognosis (ie, oesophagus, stomach, pancreas, and lung). Progress in cancer control (ie, increased survival, decreased mortality and incidence) over the study period was evident for stomach, colon, lung (in males), and ovarian cancer. Interpretation: The joint evaluation of trends in incidence, mortality, and survival indicated progress in four of the seven studied cancers. Cancer survival continues to increase across high-income countries; however, international disparities persist. While truly valid comparisons require differences in registration practice, classification, and coding to be minimal, stage of disease at diagnosis, timely access to effective treatment, and the extent of comorbidity are likely the main determinants of patient outcomes. Future studies are needed to assess the impact of these factors to further our understanding of international disparities in cancer survival. Funding: Canadian Partnership Against Cancer; Cancer Council Victoria; Cancer Institute New South Wales; Cancer Research UK; Danish Cancer Society; National Cancer Registry Ireland; The Cancer Society of New Zealand; National Health Service England; Norwegian Cancer Society; Public Health Agency Northern Ireland, on behalf of the Northern Ireland Cancer Registry; The Scottish Government; Western Australia Department of Health; and Wales Cancer Network.
BASE
WOS: 000482433800011 ; PubMed ID: 30467691 ; Purpose The aim of the current study was to further investigate the concept of previously reported high occurrence of comorbidities in obstructive sleep patients (OSA) with insomnia-like symptoms. We hypothesized that this finding at least partly is mediated by nocturnal hypoxia. Moreover, we speculated that the spectrum of the clinical OSA phenotypes differs between European geographical regions. Methods Cohort of the European Sleep Apnea Database (n = 17,325; 29.9% females) was divided into five subcohorts according to geographical region (North, East, South, West, Central) and further into four clinical presentation phenotypes based on daytime symptoms (EDS) and characteristics suggestive of insomnia. Results The insomnia phenotype (alone or together with EDS) dominated in all European regions. Isolated insomnia, however, was less common in the West. Insomnia phenotype was associated with the highest proportion of cardiovascular comorbidity (51.7% in the insomnia vs. 43.9% in the EDS type). Measures of nocturnal hypoxemia were independently associated with cardiovascular comorbidity in phenotypes with insomnia-like symptoms. The burden of comorbidities was high across all geographical regions and clinical phenotypes. Regional differences were clinically relevant for age (48 vs. 54 years), BMI (29 vs. 34 kg/m(2)), and ODI (15 vs. 32/h). Conclusion High prevalence of particularly cardiovascular comorbidity among patients with insomnia-like symptoms was linked to nocturnal hypoxemia. Considerable differences in clinical presentation were found among OSA patients across Europe. Our data underline that physicians should ask their patients with suspected OSA also for insomnia symptoms. It remains to be explored if a reduction of nocturnal hypoxemia predicts the improvement of insomnia symptoms. ; European Union COST action B26; European Respiratory Society (ERS); ResMed Inc.; Philips Respironics Inc. ; The ESADA network has received support from the European Union COST action B26. The European Respiratory Society (ERS) supports the ESADA for the second period as a Clinical Research Collaboration (CRC) (2015-2017 and 2018-2020). Unrestricted seeding grants from ResMed Inc. and Philips Respironics Inc. for establishment of the organization and the database are gratefully acknowledged.
BASE